Marseilles, France

L'Houcine Ouafik

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 4.8

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2015-2016

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: L'Houcine Ouafik: Innovator in Antibody Research

Introduction

L'Houcine Ouafik is a notable inventor based in Marseilles, France. He has made significant contributions to the field of antibody research, particularly in relation to adrenomedullin and its receptors. With a total of two patents to his name, Ouafik's work has the potential to impact drug development and therapeutic applications.

Latest Patents

Ouafik's latest patents include innovative inventions that focus on antibodies binding to adrenomedullin and its receptors. The first patent describes antibodies that bind to adrenomedullin and to proteins forming adrenomedullin receptors, highlighting their uses as drugs. The second patent emphasizes antibodies binding to the proteins forming adrenomedullin receptors and their applications as a drug. These inventions represent a significant advancement in the understanding and treatment of conditions related to adrenomedullin.

Career Highlights

Throughout his career, L'Houcine Ouafik has worked with esteemed institutions such as Université d'Aix-Marseille and Assistance Publique - Hôpitaux de Marseille. His research has contributed to the advancement of medical science, particularly in the area of therapeutic antibodies.

Collaborations

Ouafik has collaborated with notable colleagues, including Kamel Mabrouk and Pierre-Marie Martin. These partnerships have fostered a collaborative environment that enhances the research and development of innovative solutions in the field of medicine.

Conclusion

L'Houcine Ouafik is a distinguished inventor whose work in antibody research is paving the way for new therapeutic options. His contributions to the field are invaluable, and his patents reflect a commitment to advancing medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…